HomeKTTA • NASDAQ
add
Pasithea Therapeutics Corp
Previous close
$0.71
Day range
$0.69 - $0.73
Year range
$0.65 - $7.49
Market cap
5.34M USD
Avg Volume
100.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.79M | -3.89% |
Net income | -3.72M | 3.88% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.63M | 4.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.22M | -9.42% |
Total assets | 17.01M | -3.70% |
Total liabilities | 1.83M | 23.02% |
Total equity | 15.18M | — |
Shares outstanding | 7.44M | — |
Price to book | 0.35 | — |
Return on assets | -59.86% | — |
Return on capital | -67.33% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.72M | 3.88% |
Cash from operations | -3.87M | 4.21% |
Cash from investing | — | — |
Cash from financing | 5.74M | — |
Net change in cash | 1.88M | 146.41% |
Free cash flow | -2.64M | 1.08% |
About
Founded
2020
Headquarters
Website
Employees
4
